Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
Main Authors: | Noah Huizenga, Reza Zonozi, Jillian Rosenthal, Karen Laliberte, John L. Niles, Frank B. Cortazar |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024919315621 |
Similar Items
-
Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive Histology
by: Tessa K. Novick, et al.
Published: (2018-05-01) -
Minocycline-induced antineutrophil cytoplasmic antibody-associated vasculitis in children
by: Sunil Kapur, et al.
Published: (2021-01-01) -
Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis
by: T V Beketova
Published: (2018-05-01) -
Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
by: Saket Jha, et al.
Published: (2019-01-01) -
Recent advances in the management of antineutrophil cytoplasmic antibody-associated vasculitis
by: Durga Prasanna Misra, et al.
Published: (2019-01-01)